APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orexin Receptor Type 2

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Orexin Receptor Type 2 Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchOrexin Receptor Type 2 Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Orexin Receptor Type 2 Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Orexin Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orexin Receptor Type 2 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Orexin Receptor Type 2 Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Orexin Receptor Type 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Orexin Receptor Type 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Orexin Receptor Type 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Orexin Receptor Type 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Orexin Receptor Type 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Orexin Receptor Type 2 include Yangtze River Pharmaceutical Group, Eisai Co Ltd, Johnson & Johnson, Merck & Co Inc, OptiNose US Inc, Idorsia Ltd, Heptares Therapeutics Ltd, Evotec AG and Actelion Pharmaceuticals Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Orexin Receptor Type 2, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Orexin Receptor Type 2, also provides the revenue of main regions and countries. Of the upcoming market potential for Orexin Receptor Type 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Orexin Receptor Type 2 revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Orexin Receptor Type 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Orexin Receptor Type 2 revenue, projected growth trends, production technology, application and end-user industry.

Orexin Receptor Type 2 Segment by Company

Yangtze River Pharmaceutical Group

Eisai Co Ltd

Johnson & Johnson

Merck & Co Inc

OptiNose US Inc

Idorsia Ltd

Heptares Therapeutics Ltd

Evotec AG

Actelion Pharmaceuticals Ltd

Orexin Receptor Type 2 Segment by Type

HTL-6641

MK-8133

OPN-021

YNT-185

Lemborexant

Others

Orexin Receptor Type 2 Segment by Application

Major Depressive Disorder

Sleep Disorders

Narcolepsy

Insomnia

Orexin Receptor Type 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orexin Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orexin Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orexin Receptor Type 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Orexin Receptor Type 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Orexin Receptor Type 2 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orexin Receptor Type 2 revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Orexin Receptor Type 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. HTL-6641 Major Player Table 3. MK-8133 Major Player Table 4. OPN-021 Major Player Table 5. YNT-185 Major Player Table 6. Lemborexant Major Player Table 7. Others Major Player Table 8. Global Orexin Receptor Type 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Major Depressive Disorder Major Player Table 10. Sleep Disorders Major Player Table 11. Narcolepsy Major Player Table 12. Insomnia Major Player Table 13. Orexin Receptor Type 2 Industry Trends Table 14. Orexin Receptor Type 2 Industry Drivers Table 15. Orexin Receptor Type 2 Industry Opportunities and Challenges Table 16. Orexin Receptor Type 2 Industry Restraints Table 17. Global Orexin Receptor Type 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Orexin Receptor Type 2 Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Orexin Receptor Type 2 Market Share by Region (2021-2026) Table 20. Global Orexin Receptor Type 2 Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Orexin Receptor Type 2 Market Share by Region (2027-2032) Table 22. Global Orexin Receptor Type 2 Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Orexin Receptor Type 2 Revenue Market Share by Players (2021-2026) Table 24. Global Orexin Receptor Type 2 Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Orexin Receptor Type 2 Key Players Headquarters & Area Served Table 26. Global Orexin Receptor Type 2 Players, Product Type & Application Table 27. Global Orexin Receptor Type 2 Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Orexin Receptor Type 2 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Orexin Receptor Type 2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Orexin Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Orexin Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Orexin Receptor Type 2 Revenue Market Share by Type (2021-2026) Table 34. Global Orexin Receptor Type 2 Revenue Market Share by Type (2027-2032) Table 35. Global Orexin Receptor Type 2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Orexin Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Orexin Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Orexin Receptor Type 2 Revenue Market Share by Application (2021-2026) Table 39. Global Orexin Receptor Type 2 Revenue Market Share by Application (2027-2032) Table 40. Yangtze River Pharmaceutical Group Company Information Table 41. Yangtze River Pharmaceutical Group Business Overview Table 42. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product Portfolio Table 44. Yangtze River Pharmaceutical Group Recent Development Table 45. Eisai Co Ltd Company Information Table 46. Eisai Co Ltd Business Overview Table 47. Eisai Co Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Eisai Co Ltd Orexin Receptor Type 2 Product Portfolio Table 49. Eisai Co Ltd Recent Development Table 50. Johnson & Johnson Company Information Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Johnson & Johnson Orexin Receptor Type 2 Product Portfolio Table 54. Johnson & Johnson Recent Development Table 55. Merck & Co Inc Company Information Table 56. Merck & Co Inc Business Overview Table 57. Merck & Co Inc Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Merck & Co Inc Orexin Receptor Type 2 Product Portfolio Table 59. Merck & Co Inc Recent Development Table 60. OptiNose US Inc Company Information Table 61. OptiNose US Inc Business Overview Table 62. OptiNose US Inc Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. OptiNose US Inc Orexin Receptor Type 2 Product Portfolio Table 64. OptiNose US Inc Recent Development Table 65. Idorsia Ltd Company Information Table 66. Idorsia Ltd Business Overview Table 67. Idorsia Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Idorsia Ltd Orexin Receptor Type 2 Product Portfolio Table 69. Idorsia Ltd Recent Development Table 70. Heptares Therapeutics Ltd Company Information Table 71. Heptares Therapeutics Ltd Business Overview Table 72. Heptares Therapeutics Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Heptares Therapeutics Ltd Orexin Receptor Type 2 Product Portfolio Table 74. Heptares Therapeutics Ltd Recent Development Table 75. Evotec AG Company Information Table 76. Evotec AG Business Overview Table 77. Evotec AG Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Evotec AG Orexin Receptor Type 2 Product Portfolio Table 79. Evotec AG Recent Development Table 80. Actelion Pharmaceuticals Ltd Company Information Table 81. Actelion Pharmaceuticals Ltd Business Overview Table 82. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product Portfolio Table 84. Actelion Pharmaceuticals Ltd Recent Development Table 85. North America Orexin Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Orexin Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Orexin Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Orexin Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Orexin Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Orexin Receptor Type 2 Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Orexin Receptor Type 2 Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Orexin Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Orexin Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Orexin Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Orexin Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Orexin Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Orexin Receptor Type 2 Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Orexin Receptor Type 2 Revenue by Country (US$ Million) & (2027-2032) Table 99. China Orexin Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 100. China Orexin Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 101. China Orexin Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 102. China Orexin Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Orexin Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Orexin Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Orexin Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Orexin Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Orexin Receptor Type 2 Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Orexin Receptor Type 2 Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Orexin Receptor Type 2 Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Orexin Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Orexin Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Orexin Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Orexin Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Orexin Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Orexin Receptor Type 2 Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Orexin Receptor Type 2 Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Orexin Receptor Type 2 Image Figure 2. Global Orexin Receptor Type 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orexin Receptor Type 2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. HTL-6641 Image Figure 5. MK-8133 Image Figure 6. OPN-021 Image Figure 7. YNT-185 Image Figure 8. Lemborexant Image Figure 9. Others Image Figure 10. Global Orexin Receptor Type 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Orexin Receptor Type 2 Market Size Share 2021 VS 2025 VS 2032 Figure 12. Major Depressive Disorder Image Figure 13. Sleep Disorders Image Figure 14. Narcolepsy Image Figure 15. Insomnia Image Figure 16. Global Orexin Receptor Type 2 Market Size (US$ Million) & (2021-2032) Figure 17. Global Orexin Receptor Type 2 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Orexin Receptor Type 2 Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Orexin Receptor Type 2 Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Orexin Receptor Type 2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Orexin Receptor Type 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Orexin Receptor Type 2 Revenue Market Share by Type (2021-2032) Figure 24. Global Orexin Receptor Type 2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Orexin Receptor Type 2 Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Orexin Receptor Type 2 Revenue Market Share by Application (2021-2032) Figure 27. North America Orexin Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Orexin Receptor Type 2 Revenue Share by Type (2021-2032) Figure 29. North America Orexin Receptor Type 2 Revenue Share by Application (2021-2032) Figure 30. North America Orexin Receptor Type 2 Revenue Share by Country (2021-2032) Figure 31. United States Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Orexin Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Orexin Receptor Type 2 Revenue Share by Type (2021-2032) Figure 36. Europe Orexin Receptor Type 2 Revenue Share by Application (2021-2032) Figure 37. Europe Orexin Receptor Type 2 Revenue Share by Country (2021-2032) Figure 38. Germany Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Orexin Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Orexin Receptor Type 2 Revenue Share by Type (2021-2032) Figure 48. China Orexin Receptor Type 2 Revenue Share by Application (2021-2032) Figure 49. Asia Orexin Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Orexin Receptor Type 2 Revenue Share by Type (2021-2032) Figure 51. Asia Orexin Receptor Type 2 Revenue Share by Application (2021-2032) Figure 52. Asia Orexin Receptor Type 2 Revenue Share by Region (2021-2032) Figure 53. Japan Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Orexin Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Orexin Receptor Type 2 Revenue Share by Type (2021-2032) Figure 61. SAMEA Orexin Receptor Type 2 Revenue Share by Application (2021-2032) Figure 62. SAMEA Orexin Receptor Type 2 Revenue Share by Country (2021-2032) Figure 63. Brazil Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Orexin Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • HTL-6641
  • MK-8133
  • OPN-021
  • YNT-185
  • Lemborexant
  • Others
Applications
  • Major Depressive Disorder
  • Sleep Disorders
  • Narcolepsy
  • Insomnia
Companies covered
  • Yangtze River Pharmaceutical Group
  • Eisai Co Ltd
  • Johnson & Johnson
  • Merck & Co Inc
  • OptiNose US Inc
  • Idorsia Ltd
  • Heptares Therapeutics Ltd
  • Evotec AG
  • Actelion Pharmaceuticals Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Orexin Receptor Type 2 Market by Type
  3. 1.2.1 Global Orexin Receptor Type 2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 HTL-6641
  5. 1.2.3 MK-8133
  6. 1.2.4 OPN-021
  7. 1.2.5 YNT-185
  8. 1.2.6 Lemborexant
  9. 1.2.7 Others
  10. 1.3 Orexin Receptor Type 2 Market by Application
  11. 1.3.1 Global Orexin Receptor Type 2 Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Major Depressive Disorder
  13. 1.3.3 Sleep Disorders
  14. 1.3.4 Narcolepsy
  15. 1.3.5 Insomnia
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Orexin Receptor Type 2 Market Dynamics
  1. 2.1 Orexin Receptor Type 2 Industry Trends
  2. 2.2 Orexin Receptor Type 2 Industry Drivers
  3. 2.3 Orexin Receptor Type 2 Industry Opportunities and Challenges
  4. 2.4 Orexin Receptor Type 2 Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Orexin Receptor Type 2 Market Perspective (2021-2032)
  2. 3.2 Global Orexin Receptor Type 2 Growth Trends by Region
  3. 3.2.1 Global Orexin Receptor Type 2 Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Orexin Receptor Type 2 Market Size by Region (2021-2026)
  5. 3.2.3 Global Orexin Receptor Type 2 Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Orexin Receptor Type 2 Revenue by Players
  2. 4.1.1 Global Orexin Receptor Type 2 Revenue by Players (2021-2026)
  3. 4.1.2 Global Orexin Receptor Type 2 Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Orexin Receptor Type 2 Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Orexin Receptor Type 2 Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Orexin Receptor Type 2 Key Players Headquarters & Area Served
  7. 4.4 Global Orexin Receptor Type 2 Players, Product Type & Application
  8. 4.5 Global Orexin Receptor Type 2 Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Orexin Receptor Type 2 Market CR5 and HHI
  11. 4.6.3 2025 Orexin Receptor Type 2 Tier 1, Tier 2, and Tier 3
5 Orexin Receptor Type 2 Market Size by Type
  1. 5.1 Global Orexin Receptor Type 2 Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Orexin Receptor Type 2 Revenue by Type (2021-2032)
  3. 5.3 Global Orexin Receptor Type 2 Revenue Market Share by Type (2021-2032)
6 Orexin Receptor Type 2 Market Size by Application
  1. 6.1 Global Orexin Receptor Type 2 Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Orexin Receptor Type 2 Revenue by Application (2021-2032)
  3. 6.3 Global Orexin Receptor Type 2 Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Yangtze River Pharmaceutical Group
  2. 7.1.1 Yangtze River Pharmaceutical Group Company Information
  3. 7.1.2 Yangtze River Pharmaceutical Group Business Overview
  4. 7.1.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product Portfolio
  6. 7.1.5 Yangtze River Pharmaceutical Group Recent Developments
  7. 7.2 Eisai Co Ltd
  8. 7.2.1 Eisai Co Ltd Company Information
  9. 7.2.2 Eisai Co Ltd Business Overview
  10. 7.2.3 Eisai Co Ltd Orexin Receptor Type 2 Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eisai Co Ltd Orexin Receptor Type 2 Product Portfolio
  12. 7.2.5 Eisai Co Ltd Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Orexin Receptor Type 2 Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Orexin Receptor Type 2 Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Merck & Co Inc
  20. 7.4.1 Merck & Co Inc Company Information
  21. 7.4.2 Merck & Co Inc Business Overview
  22. 7.4.3 Merck & Co Inc Orexin Receptor Type 2 Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Merck & Co Inc Orexin Receptor Type 2 Product Portfolio
  24. 7.4.5 Merck & Co Inc Recent Developments
  25. 7.5 OptiNose US Inc
  26. 7.5.1 OptiNose US Inc Company Information
  27. 7.5.2 OptiNose US Inc Business Overview
  28. 7.5.3 OptiNose US Inc Orexin Receptor Type 2 Revenue and Gross Margin (2021-2026)
  29. 7.5.4 OptiNose US Inc Orexin Receptor Type 2 Product Portfolio
  30. 7.5.5 OptiNose US Inc Recent Developments
  31. 7.6 Idorsia Ltd
  32. 7.6.1 Idorsia Ltd Company Information
  33. 7.6.2 Idorsia Ltd Business Overview
  34. 7.6.3 Idorsia Ltd Orexin Receptor Type 2 Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Idorsia Ltd Orexin Receptor Type 2 Product Portfolio
  36. 7.6.5 Idorsia Ltd Recent Developments
  37. 7.7 Heptares Therapeutics Ltd
  38. 7.7.1 Heptares Therapeutics Ltd Company Information
  39. 7.7.2 Heptares Therapeutics Ltd Business Overview
  40. 7.7.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Heptares Therapeutics Ltd Orexin Receptor Type 2 Product Portfolio
  42. 7.7.5 Heptares Therapeutics Ltd Recent Developments
  43. 7.8 Evotec AG
  44. 7.8.1 Evotec AG Company Information
  45. 7.8.2 Evotec AG Business Overview
  46. 7.8.3 Evotec AG Orexin Receptor Type 2 Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Evotec AG Orexin Receptor Type 2 Product Portfolio
  48. 7.8.5 Evotec AG Recent Developments
  49. 7.9 Actelion Pharmaceuticals Ltd
  50. 7.9.1 Actelion Pharmaceuticals Ltd Company Information
  51. 7.9.2 Actelion Pharmaceuticals Ltd Business Overview
  52. 7.9.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product Portfolio
  54. 7.9.5 Actelion Pharmaceuticals Ltd Recent Developments
8 North America
  1. 8.1 North America Orexin Receptor Type 2 Revenue (2021-2032)
  2. 8.2 North America Orexin Receptor Type 2 Revenue by Type (2021-2032)
  3. 8.2.1 North America Orexin Receptor Type 2 Revenue by Type (2021-2026)
  4. 8.2.2 North America Orexin Receptor Type 2 Revenue by Type (2027-2032)
  5. 8.3 North America Orexin Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 8.4 North America Orexin Receptor Type 2 Revenue by Application (2021-2032)
  7. 8.4.1 North America Orexin Receptor Type 2 Revenue by Application (2021-2026)
  8. 8.4.2 North America Orexin Receptor Type 2 Revenue by Application (2027-2032)
  9. 8.5 North America Orexin Receptor Type 2 Revenue Share by Application (2021-2032)
  10. 8.6 North America Orexin Receptor Type 2 Revenue by Country
  11. 8.6.1 North America Orexin Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Orexin Receptor Type 2 Revenue by Country (2021-2026)
  13. 8.6.3 North America Orexin Receptor Type 2 Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Orexin Receptor Type 2 Revenue (2021-2032)
  2. 9.2 Europe Orexin Receptor Type 2 Revenue by Type (2021-2032)
  3. 9.2.1 Europe Orexin Receptor Type 2 Revenue by Type (2021-2026)
  4. 9.2.2 Europe Orexin Receptor Type 2 Revenue by Type (2027-2032)
  5. 9.3 Europe Orexin Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 9.4 Europe Orexin Receptor Type 2 Revenue by Application (2021-2032)
  7. 9.4.1 Europe Orexin Receptor Type 2 Revenue by Application (2021-2026)
  8. 9.4.2 Europe Orexin Receptor Type 2 Revenue by Application (2027-2032)
  9. 9.5 Europe Orexin Receptor Type 2 Revenue Share by Application (2021-2032)
  10. 9.6 Europe Orexin Receptor Type 2 Revenue by Country
  11. 9.6.1 Europe Orexin Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Orexin Receptor Type 2 Revenue by Country (2021-2026)
  13. 9.6.3 Europe Orexin Receptor Type 2 Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Orexin Receptor Type 2 Revenue (2021-2032)
  2. 10.2 China Orexin Receptor Type 2 Revenue by Type (2021-2032)
  3. 10.2.1 China Orexin Receptor Type 2 Revenue by Type (2021-2026)
  4. 10.2.2 China Orexin Receptor Type 2 Revenue by Type (2027-2032)
  5. 10.3 China Orexin Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 10.4 China Orexin Receptor Type 2 Revenue by Application (2021-2032)
  7. 10.4.1 China Orexin Receptor Type 2 Revenue by Application (2021-2026)
  8. 10.4.2 China Orexin Receptor Type 2 Revenue by Application (2027-2032)
  9. 10.5 China Orexin Receptor Type 2 Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Orexin Receptor Type 2 Revenue (2021-2032)
  2. 11.2 Asia Orexin Receptor Type 2 Revenue by Type (2021-2032)
  3. 11.2.1 Asia Orexin Receptor Type 2 Revenue by Type (2021-2026)
  4. 11.2.2 Asia Orexin Receptor Type 2 Revenue by Type (2027-2032)
  5. 11.3 Asia Orexin Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 11.4 Asia Orexin Receptor Type 2 Revenue by Application (2021-2032)
  7. 11.4.1 Asia Orexin Receptor Type 2 Revenue by Application (2021-2026)
  8. 11.4.2 Asia Orexin Receptor Type 2 Revenue by Application (2027-2032)
  9. 11.5 Asia Orexin Receptor Type 2 Revenue Share by Application (2021-2032)
  10. 11.6 Asia Orexin Receptor Type 2 Revenue by Country
  11. 11.6.1 Asia Orexin Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Orexin Receptor Type 2 Revenue by Country (2021-2026)
  13. 11.6.3 Asia Orexin Receptor Type 2 Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Orexin Receptor Type 2 Revenue (2021-2032)
  2. 12.2 SAMEA Orexin Receptor Type 2 Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Orexin Receptor Type 2 Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Orexin Receptor Type 2 Revenue by Type (2027-2032)
  5. 12.3 SAMEA Orexin Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Orexin Receptor Type 2 Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Orexin Receptor Type 2 Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Orexin Receptor Type 2 Revenue by Application (2027-2032)
  9. 12.5 SAMEA Orexin Receptor Type 2 Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Orexin Receptor Type 2 Revenue by Country
  11. 12.6.1 SAMEA Orexin Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Orexin Receptor Type 2 Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Orexin Receptor Type 2 Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst